Cracking The Code: Understanding Carcinoma Of Bladder ICD-10

What is Carcinoma of Bladder ICD-10?

Carcinoma of bladder ICD-10 is a medical code used to classify and document cases of bladder cancer in the International Classification of Diseases, 10th revision (ICD-10). This code specifically refers to malignant neoplasms of the bladder, which can be classified further based on the specific type and location of the cancerous cells.

Code Information

The ICD-10 code for carcinoma of bladder is C67. This code is further classified into subcategories based on the histology of the tumor, such as transitional cell carcinoma, squamous cell carcinoma, adenocarcinoma, and others. The specific code used will depend on the type and extent of the bladder cancer.

Diagnostic Related Groups (MS-DRG)

Bladder Cancer & Its Related ICD- Diagnosis Codes
Bladder Cancer & Its Related ICD- Diagnosis Codes

For billing and reimbursement purposes, carcinoma of bladder cases are typically grouped into specific Diagnostic Related Groups (MS-DRG) based on factors such as the severity of the cancer, the patient’s age and comorbidities, and the type of treatment received. This grouping helps healthcare providers and insurers determine appropriate payment for services rendered.

Convert to ICD-9 Code

For those still using the older ICD-9 coding system, carcinoma of bladder is classified under code 188.9. It is important to convert this code to the more updated ICD-10 system to ensure accurate and up-to-date documentation of bladder cancer cases.

Code History

ICD--CM Diagnosis Code C
ICD–CM Diagnosis Code C

The ICD-10 code for carcinoma of bladder has undergone several revisions over the years to reflect advances in medical knowledge and technology. The current code C67 provides a more detailed classification of bladder cancer cases, allowing for better tracking and analysis of these malignancies.

Approximate Synonyms

Some approximate synonyms for carcinoma of bladder include bladder cancer, urothelial carcinoma, and urinary bladder neoplasm. These terms may be used interchangeably in medical literature and documentation to refer to the same condition.

Clinical Information

Carcinoma of bladder is a type of cancer that originates in the cells lining the bladder wall. It is most commonly associated with smoking and exposure to certain chemicals, such as those found in industrial settings. Symptoms of bladder cancer may include blood in the urine, frequent urination, and pelvic pain.


The exact cause of bladder cancer is not fully understood, but certain risk factors have been identified. These include smoking, exposure to chemicals such as arsenic and benzene, chronic bladder inflammation, and a family history of the disease. It is important to reduce these risk factors to lower the chances of developing bladder cancer.


Symptoms of carcinoma of bladder may vary depending on the stage and severity of the cancer. Common symptoms include blood in the urine (hematuria), urinary urgency and frequency, pain during urination, and lower back or pelvic pain. If you experience any of these symptoms, it is important to seek medical attention promptly for evaluation and diagnosis.


Diagnosis of carcinoma of bladder typically involves a combination of medical history review, physical examination, imaging tests (such as CT scans or ultrasounds), and urine tests to detect abnormal cells or blood. A definitive diagnosis is often made through a cystoscopy, where a thin tube with a camera is inserted into the bladder to visualize any abnormalities.


Treatment options for carcinoma of bladder may include surgery to remove the cancerous cells, chemotherapy or immunotherapy to target and kill cancer cells, and radiation therapy to shrink tumors and alleviate symptoms. The choice of treatment will depend on the stage of the cancer, the patient’s overall health, and other factors that may impact the outcome.


Carcinoma of bladder ICD-10 is a specific code used to classify cases of bladder cancer in the updated international coding system. Proper documentation and coding of bladder cancer cases are essential for accurate diagnosis, treatment, and reimbursement. Early detection and prompt treatment of carcinoma of bladder are crucial for improving outcomes and quality of life for patients affected by this condition.


1. Can bladder cancer be prevented?

While the exact cause of bladder cancer is unknown, there are steps you can take to reduce your risk, such as avoiding smoking and exposure to harmful chemicals.

2. What are the treatment options for bladder cancer?

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button